Atherosclerosis
Volume 183, Issue 1 , Pages 85-93 , November 2005

Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-β from its activation

  • Yu-ichiro Sakamoto

      Affiliations

    • Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 96 373 5072; fax: +81 96 364 6940.
    • ,
  • Akira Miyazaki

      Affiliations

    • Department of Biochemistry, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan
    • ,
  • Harumi Tamagawa

      Affiliations

    • Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan
    • ,
  • Guo-Ping Wang

      Affiliations

    • Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan
    • ,
  • Seikoh Horiuchi

      Affiliations

    • Department of Medical Biochemistry, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan

Received 5 August 2004 ,Revised 25 February 2005 ,Accepted 25 February 2005.

References 

  1. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998;16:137–161
  2. Miyazono K, Hellman U, Wernstedt C, et al. Latent high molecular weight complex of transforming growth factor-beta 1. Purification from human platelets and structural characterization. J Biol Chem. 1988;263:6407–6415
  3. Lyons RM, Gentry LE, Purchio AF, et al. Mechanism of activation of latent recombinant transforming growth factor-beta 1 by plasmin. J Cell Biol. 1990;110:1361–1367
  4. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1988;106:1659–1665
  5. Abe M, Oda N, Sato Y. Cell-associated activation of latent transforming growth factor-beta by calpain. J Cell Physiol. 1998;174:186–193
  6. Persson U, Souchelnytskyi S, Franzen P, et al. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor. J Biol Chem. 1997;272:21187–21194
  7. Nakao A, Imamura T, Souchelnytskyi S, et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 1997;16:5353–5362
  8. Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol. 1993;122:923–932
  9. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell. 1998;93:1159–1170
  10. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor-beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 1993;90:770–774
  11. Geiser AG, Letterio JJ, Kulkarni AB, et al. Transforming growth factor-beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci USA. 1993;90:9944–9948
  12. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915–924
  13. Yla-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086–1095
  14. Kohno M, Yokokawa K, Yasunari K, et al. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ Res. 1997;81:585–590
  15. Aoyama T, Fujiwara H, Masaki T, et al. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol. 1999;31:2101–2114
  16. Nozaki S, Kashiwagi H, Yamashita S, et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest. 1995;96:1859–1865
  17. Mallat Z, Tedgui A. The role of transforming growth factor-beta in atherosclerosis: novel insights and future perspectives. Curr Opin Lipidol. 2002;13:523–529
  18. Ohgami N, Nagai R, Ikemoto M, et al. CD36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem. 2001;276:3195–3202
  19. Miyazaki A, Sakai M, Suginohara Y, et al. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein. J Biol Chem. 1994;269:5259–5264
  20. Takata K, Horiuchi S, Morino Y. Scavenger receptor-mediated recognition of maleylated albumin and its relation to subsequent endocytic degradation. Biochim Biophys Acta. 1989;984:273–280
  21. McFarlane AS. Efficient trace-labelling of proteins with iodine. Nature. 1958;182:53
  22. Yamashita H, ten Dijke P, Huylebroeck D, et al. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol. 1995;130:217–226
  23. Parthasarathy S, Santanam N, Ramachandran S, et al. Oxidants and antioxidants in atherogenesis. An appraisal. J Lipid Res. 1999;40:2143–2157
  24. Ribeiro SM, Poczatek M, Schultz-Cherry S, et al. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem. 1999;274:13586–13593
  25. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J Biol Chem. 1994;269:26783–26788
  26. Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol. 2000;19:597–614
  27. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest. 2001;108:785–791
  28. Yehualaeshet T, O’Connor R, Green-Johnson J, et al. Activation of rat alveolar macrophage-derived latent transforming growth factor-beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol. 1999;155:841–851
  29. Oka H, Kugiyama K, Doi H, et al. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway. Arterioscler Thromb Vasc Biol. 2000;20:244–250
  30. Kugiyama K, Sakamoto T, Misumi I, et al. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ Res. 1993;73:335–343
  31. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor-beta in human disease. N Engl J Med. 2000;342:1350–1358
  32. Erren M, Reinecke H, Junker R, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol. 1999;19:2355–2363
  33. Mallat Z, Gojova A, Marchiol-Fournigault C, et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res. 2001;89:930–934
  34. Lutgens E, Gijbels M, Smook M, et al. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol. 2002;22:975–982
  35. Draude G, Lorenz RL. TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am J Physiol Heart Circ Physiol. 2000;278:H1042–H1048
  36. Argmann CA, Van Den , Diepstraten CH, et al. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol. 2001;21:2011–2018

PII: S0021-9150(05)00200-5

doi: 10.1016/j.atherosclerosis.2005.02.032

Atherosclerosis
Volume 183, Issue 1 , Pages 85-93 , November 2005

Article Tools

* Image Usage & Resolution